Laidlaw Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,112
Closed -$409K 119
2024
Q4
$409K Sell
4,112
-3,136
-43% -$323K 0.18% 125
2024
Q3
$823K Buy
7,248
+867
+14% +$103K 0.41% 68
2024
Q2
$790K Buy
6,381
+1,625
+34% +$209K 0.43% 63
2024
Q1
$628K Sell
4,756
-5,873
-55% -$724K 0.35% 89
2023
Q4
$1.16M Sell
10,629
-2,319
-18% -$241K 0.42% 73
2023
Q3
$1.33M Sell
12,948
-15,549
-55% -$1.68M 0.44% 67
2023
Q2
$3.29M Buy
28,497
+444
+2% +$50.4K 0.64% 38
2023
Q1
$2.98M Sell
28,053
-5,134
-15% -$554K 0.61% 39
2022
Q4
$3.68M Sell
33,187
-79
-0.2% -$8.07K 0.79% 25
2022
Q3
$2.87M Buy
33,266
+2,582
+8% +$230K 0.67% 37
2022
Q2
$2.8M Buy
30,684
+3,505
+13% +$311K 0.57% 45
2022
Q1
$2.23M Buy
27,179
+4,106
+18% +$324K 0.37% 68
2021
Q4
$1.77M Sell
23,073
-2,686
-10% -$214K 0.28% 97
2021
Q3
$1.94M Buy
25,759
+2,396
+10% +$182K 0.5% 56
2021
Q2
$1.82M Sell
23,363
-449
-2% -$33.4K 0.47% 58
2021
Q1
$1.75M Buy
23,812
+2,409
+11% +$178K 0.6% 47
2020
Q4
$1.67M Buy
21,403
+10,586
+98% +$810K 0.35% 77
2020
Q3
$856K Buy
10,817
+1,635
+18% +$128K 0.38% 77
2020
Q2
$677K Buy
9,182
+735
+9% +$55.3K 0.35% 79
2020
Q1
$620K Sell
8,447
-213
-2% -$16.7K 0.41% 73
2019
Q4
$751K Buy
+8,660
New +$711K 0.47% 71

Other funds holding MRK

Laidlaw Wealth Management's MRK Position: Q1 2025 in Review

Laidlaw Wealth Management sold out of Merck (MRK) in Q1 2025, closing a stake of 4,112 shares — an estimated $409K sold.

Laidlaw Wealth Management first reported a position in MRK in Q4 2019 and held it in 21 quarters. The position peaked at $3.68M in Q4 2022. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Laidlaw Wealth Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Laidlaw Wealth Management sold 4,112 Merck shares in Q1 2025, an estimated $409K.
  • Laidlaw Wealth Management first reported a position in Merck in Q4 2019 and held it in 21 quarters.
  • Laidlaw Wealth Management's Merck position peaked at $3.68M in Q4 2022.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Laidlaw Wealth Management's 13F filing for Q1 2025, filed 16 May 2025.